Back to top
more

Integer Holdings (ITGR)

(Delayed Data from NYSE)

$121.24 USD

121.24
251,366

-0.41 (-0.34%)

Updated May 31, 2024 04:00 PM ET

After-Market: $121.16 -0.08 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (147 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Varian Acquires humediQ, Boosts Motion Management Portfolio

Varian (VAR) incorporates humediQ's coveted IDENTIFY technology in its comprehensive suite of oncology solutions.

    Allscripts Sunrise Picked by UK's Maidstone and Tunbridge Wells

    Allscripts' (MDRX) Sunrise platform witnesses a suite of developments, fortifying the company's global foothold.

      OPKO Health (OPK) Earnings & Revenues Beat Estimates in Q2

      OPKO Health (OPK) gains from robust demand for its flagship RAYALDEE; declining segmental revenues raise concern.

        Buy 3 Stocks With Rising Cash Flows to Scoop Up Big Gains

        Even though profit is a company's goal, cash is its lifeblood for existence and a measure of resiliency.

          Allscripts Gains From Strong Results in Q2, Competition Rife

          Allscripts (MDRX) continues to gain from solid Q2 results and EHR developments; a competitive industry is a concern.

            Inogen (INGN) Beats on Q2 Earnings, Lifts '18 Sales Guidance

            Inogen (INGN) puts up solid segmental show in Q2; international sales surge.

              Zacks.com highlights: Turtle Beach, PetroChina, Harsco, Integer Holdings and Triton International

              Zacks.com highlights: Turtle Beach, PetroChina, Harsco, Integer Holdings and Triton International

                5 Top Stocks With Striking Net Profit Margin

                Five stocks with handsome net profit margin that investors can count on for stellar returns.

                  Integer Holdings (ITGR) Beats on Q2 Earnings, '18 View Solid

                  Integer Holdings (ITGR) gains on solid Cardio & Vascular revenues and high organic sales; a solid guidance raises optimism.

                    Hill-Rom (HRC) Q3 Earnings Top Estimates, Margins Expand

                    Hill-Rom (HRC) registers a solid year-over-year revenue rise on strong domestic growth, driven by a robust performance at Patient Support Systems and Surgical Solutions.

                      ITGR vs. ABMD: Which Stock Is the Better Value Option?

                      ITGR vs. ABMD: Which Stock Is the Better Value Option?

                        Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, Margins Drop

                        The improvement within Zimmer Biomet's (ZBH) global Knee and Hip sales performance and ongoing growth within the Asia Pacific region are encouraging.

                          GNC Holdings (GNC) Q2 Earnings Beat, Revenues Miss Mark

                          Though GNC Holdings' (GNC) domestic retail comps are slightly weaker than expected, the company performs strongly in e-commerce business and at International segment.

                            Baxter (BAX) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

                            Baxter (BAX) gains on the back of its core Renal Care segment in Q2; solid international sales encourage.

                              Zacks.com highlights: Hitachi, Integer Holdings, Panasonic and SunCoke Energy

                              Zacks.com highlights: Hitachi, Integer Holdings, Panasonic and SunCoke Energy

                                Align Technology (ALGN) Beats on Earnings and Revenues in Q2

                                Align Technology (ALGN) gains on solid contributions from Clear Aligner as well as Scanner and Service segments in Q2.

                                  Chemed (CHE) Beats on Q2 Earnings & Revenues, View Raised

                                  Chemed (CHE) rides on strong contributions from the Roto-Rooter and VITAS businesses in Q2.

                                    Stryker (SYK) Beats on Q2 Earnings, International Sales Up

                                    Stryker (SYK) gains from solid segmental performance in Q2.

                                      Medidata (MDSO) Q2 Earnings Beat, Revenues Miss Estimates

                                      Medidata (MDSO) gains from solid segmental performance in Q2; banks on strategic buyouts.

                                        Boston Scientific (BSX) Beats on Q2 Earnings, Margins Down

                                        Boston Scientific (BSX) registers steady growth across all business lines and geographies in Q2.

                                          Look Beyond Earnings: 4 Stocks With Increasing Cash Flows

                                          Cash is indispensable to any company. It gives strength and vitality to a company and is the key to its existence, development and success.

                                            Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online

                                            Zacks.com highlights: Integer Holdings, Stars Group, Turtle Beach, FTI Consulting, and Yatra Online

                                              5 Stocks in Focus on New Analyst Coverage

                                              Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.

                                                Quest Diagnostics (DGX) Q2 Earnings Meet, Guidance Narrowed

                                                Quest Diagnostics (DGX) gains on successful execution of its two-point strategy of accelerating growth and driving operational excellence in Q2.

                                                  Nalak Das headshot

                                                  5 Low-Beta Stocks to Combat Trade & Geopolitical Tensions

                                                  The United States and China are yet to reach any sort of understanding to defuse trade tensions between the countries.